Effects of nicotinamide supplementation in normal-tension glaucoma: a crossover placebo-controlled randomised clinical trial.

Br J Ophthalmol · 2026 · PMC13018849 · PMID 41167798

Europe PMC DOI

hedged sentence

0.2900

closest p · 5.8× alpha

0.2900

boldest claim

The sentences

did not reach statistical significancep=0.29not close (p > 0.1)

The mean number of pointwise improvements on total deviation and PSD was higher in NAM-treated eyes (1.146±1.49 and 1.146±1.53) compared with placebo-treated eyes (0.829±1.20 and 0.781±1.13); however, the difference did not reach statistical significance (p=0.29 and p=0.22, respectively).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.